Blog

In April 2020, the U.S Food and Drug Administration (FDA) issued a recall for the heartburn medication Zantac, after carcinogenic impurities were found in samples of the prescription drug. The recall, along with a surge in reports of serious complications …

Mass tort claims are legal actions filed by a group of injured plaintiffs, as opposed to individual lawsuits that typically have one injured party. Unlike class-action lawsuits, mass torts treat each plaintiff separately, and if the case results in a …

Eisai Inc., a subsidiary of Japanese pharmaceutical company Eisai Co., Ltd, manufactures weight loss medications Belviq and Belviq XR — but in February 2020, the manufacturer voluntarily pulled these drugs from the market. This decision came after the Food and …

All civil lawsuits across the United States are subject to a rule known as the statute of limitations, which sets a deadline for filing a claim. In many cases, if you do not file your claim by the established deadline, …

Compared to established drugs that have been on the market for years, little is known about the weight loss medications Belviq and Belviq XR. In February 2020, the Food and Drug Administration (FDA) asked the manufacturers of Belviq to pull …

If you have extra Belviq or Belviq XR pills, you should take the medication to a drug take back location in your local area. The FDA provides a list of drug take back programs, including permanent drop-off locations and …

Many Americans struggle with obesity, even with a healthy diet and regular exercise. In these situations, doctors may prescribe weight loss medications to help increase the effectiveness of diet and exercise regimens. The Food and Drug Administration asked for the …

Losing weight can be difficult with diet and exercise alone, which is why some doctors prescribe weight loss medications to their patients. One of these drugs, Belviq, may lead to an increased risk of colorectal, pancreatic, and lung cancers, according …

Belviq is a weight loss medication that may increase the risk of certain cancers. After its initial approval in 2012 by the Food and Drug Administration (FDA), a mandated five-year clinical trial discovered that Belviq patients developed cancer at a …

The weight loss medication Belviq aims to help patients who struggle with obesity by suppressing appetite and promoting feelings of fullness. This drug is no longer available for prescription, due to findings regarding its potential cancer risk.

In February 2020, …